Monte Rosa Therapeutics, Inc. Share Price
Equities
GLUE
US61225M1027
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +0.89% | +6.00% | 0.00% |
Sales 2024 * | 6.18M 493M | Sales 2025 * | 5.93M 473M | Capitalization | 282M 22.46B |
---|---|---|---|---|---|
Net income 2024 * | -143M -11.4B | Net income 2025 * | -171M -13.63B | EV / Sales 2024 * | 25.9 x |
Net cash position 2024 * | 122M 9.69B | Net cash position 2025 * | 171M 13.66B | EV / Sales 2025 * | 18.6 x |
P/E ratio 2024 * |
-2.44
x | P/E ratio 2025 * |
-2.44
x | Employees | 133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Monte Rosa Therapeutics, Inc.
1 day | +0.89% | ||
1 week | +3.67% | ||
Current month | +6.20% | ||
1 month | -16.91% | ||
3 months | +19.70% | ||
6 months | +62.82% |
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 31/12/19 |
Chief Operating Officer | - | 28/02/21 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 31/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 31/08/20 |
Christine Siu
BRD | Director/Board Member | 47 | 30/11/20 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 31/08/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.90% | - |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 5.65 | +0.89% | 80,628 |
02/05/24 | 5.6 | -5.72% | 176,103 |
01/05/24 | 5.94 | +11.65% | 156,396 |
30/04/24 | 5.32 | -5.17% | 92,522 |
29/04/24 | 5.61 | +5.25% | 89,395 |
Delayed Quote Nasdaq, May 03, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 282M | |
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |
- Stock Market
- Equities
- GLUE Stock